CN
|
EN
Home
Introduction to the 2024 CBIIC
Main Conference
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Previous Speakers
News
Home
About CBIIC
Agenda
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Previous Speakers
News
Expert
Business Matching Service
Register
Roadshow Application
Onsite Participant Registration
CN
EN
Non-Listed Company Roadshow
Agendas
14:00 - 17:40
非上市公司路演专场
Non-Listed Company Roadshow
Moderator
杜向阳 , 西南证券研发中心副所长,医药首席分析师
DU Xiangyang , Deputy Director and Chief Healthcare Analyst of Southwest Securities Equity Research Department
14:00 - 14:20
主旨报告
Keynote Speech
大数据赋能立项研发与交易:从“预见未来”到“遇见未来”
Big Data Enabling Project R&D and Trading: from "Foreseeing the Future" to "Meeting the Future"
龚元香 珠海横琴濠麦科技有限公司总经理兼董事长
Lena.GONG , General Manager and Chairman of Zhuhai Hengqin Haomai Ttechnology Co., Ltd.
14:20 - 14:40
项目 1
Project 1
神经再生型基因疗法新进展
Advancement of Neuroregenerative Gene Therapy
陈功 广州神曦馨盛生物医药有限公司创始人 董事长
CHEN Gong , Founder & Chairman, NeuExcell Therapeutics Inc.
14:40 - 15:00
项目 2
Project 2
麓鹏制药 专注新一代抗肿瘤小分子靶向创新药物的开发和商业化
Lupeng Pharmaceutical:Focus on the Development and Commercialization of A New Generation of Small Molecule Targeted Anti-Tumor Innovative Drugs
谭芬来 广州麓鹏制药有限公司董事长
TAN Fenlai , Chairman, Guangzhou Lupeng Pharmaceuticals, Inc.
15:00 - 15:20
项目 3
Project 3
开发颠覆性创新药产品,应对感染性疾病领域新挑战
Developing Disruptive Therapies to Meet New Challenges in the Field of Infectious Diseases
马振坤 丹诺医药(苏州)有限公司执行总裁
MA Zhenkun , CEO, TenNor Therapeutics (Suzhou) Limited
15:20 - 15:40
项目 4
Project 4
基于U-VLP™创新技术平台的疫苗研发和产业化
The R&D and Commercialization of Vaccine Products Utilizing U-VLP™ Innovative Technology Platform
晋竞 广州派诺生物技术有限公司首席执行官
JIN Jing , CEO, Guangzhou Patronus Biotech Co., Ltd.
15:40 - 16:00
项目 5
Project 5
帝奇医药长效制剂开发及产业化
Technology Platform and Pipelines for Development and Commercialization of Long-Acting Products by DiQi Pharma
刘锋 广州帝奇医药技术有限公司总经理
LIU Feng , General Manager, Guangzhou DiQi Pharmaceuticals Co., Ltd.
16:00 - 16:20
项目 6
Project 6
畅溪制药:创新型干粉吸入药物的开发
Chance Pharmaceuticals: Development of Innovative Dry Powder Inhalation Drugs
赵国宝 杭州畅溪制药有限公司高级副总裁
ZHAO Guobao , Sr. Vice President, Hangzhou Chance Pharmaceuticals Co., Ltd.
16:20 - 16:40
项目 7
Project 7
儿童呼吸疾病创新药开发和商业化项目
Innovative Drug Development and Commercialization for Children and Respiratory Diseases
袁海卿 上海爱科百发生物医药技术股份有限公司首席运营官
YUAN Haiqing , COO, Shanghai Ark Biopharmaceutical Co., Ltd.
16:40 - 17:00
项目 8
Project 8
治疗性核酸疫苗研发平台STARi及其应用
STARi:Nucleic Acid Vaccine Research and Development Platform and Its Applications
汪卫坤 诺未生物技术(无锡)有限公司首席运营官
WANG Weikun , COO, NEWISH BIOTECH (WUXI) CO., Ltd.
17:00 - 17:20
项目 9
Project 9
溶瘤纳米颗粒的开发应用
Development and Application of Oncolytic Nanoparticles
胡翰 武汉滨会生物科技股份有限公司研发总监
HU Han , R&D Director, Wuhan Binhui Biopharmaceutical Co., Ltd.
17:20 - 17:40
项目 10
Project 10
多模态神经行为学AI大模型Animism™助力药物开发
Multimodal Neurobehavioral AI Large Model - Animism Accelerates Preclinical Drug Development
任俊名 泰康诺生物科技有限公司首席执行官
REN Junming , CEO, Taikangnuo Biotechnology Limited